Digging below the bottom lines of ingredients suppliers and brand behemoths. From the impact of the ongoing economic slowdown to the latest in merger and acquisition activity.
Favourable consumer trends for healthy formulations and natural flavours ensured steady growth in the ingredients and flavours segment of Kerry Group.
Swedish probiotics player BioGaia is welcoming a 5-year, €50.8m extension to a licensing deal with Nestlé for use of its Lactobacillus reuteri probiotic strain in infant nutrition products.
Danone and Mead Johnson may make a joint bid for the €8bn infant nutrition-dominated Pfizer nutrition business that is up for sale, according to press reports.
Swedish probiotics supplier Probi has turned in healthy annual figures with sales up 17% to SEK94.4m (€10.67m) in 2011 from SEK80.4 (€9.90m) in 2010.
Dutch firm Newtricious has won undisclosed funding from a local investment consortium that will advance its egg-focused R&D to drive products to shelves in, “two to three years”.
Chr. Hansen’s first quarter results for financial year 2011/12 are a notch stronger than analysts had expected.
€650m Dutch supplier Barentz Europe has built on its ever-expanding European and global presence by acquiring UK life sciences firm, Forum Products Ltd for an undisclosed sum.
Is there appetite for M&A activity in 2012? Food market watchers reckon the sector could see some heavyweight deals next year despite the on-going credit lending challenges.
Israeli soy player Solbar was acquired by the US farmers co-op, CHS last month, an acquisition the company welcomes for more than just financial reasons after some difficult years.
The United States’ biggest farmer-owned cooperative CHS Inc. has signed an agreement to acquire soy protein company Solbar for $133m, sending share prices in the Israeli company soaring.
Irish dairy ingredients and cheese manufacturer Glanbia could be on the look-out for acquisitions again in 2012, according to an analyst based in the country.
Chr. Hansen’s full-year results are in line with expectations, says an analyst, but positives noted were the suppliers’ expectations for its EBIT margin growth and the better performance for its...
The Swedish Competition Authority (Konkurrensverket) has approved Arla’s merger with struggling Swedish dairy processor Milko, which had faced bankruptcy in the event of the deal not going through.
Italian botanical extracts giant Indena has gained an undisclosed shareholding in US supplements manufacturer, Thorne Research, that will see the two working to expand their presence in areas like cancer...
French botanicals supplier has seen profits rise 28% to €9.7m in the first half of 2011 compared to H1 2010, and says its policy of seeking acquisitions remains unchanged.
A modest weakening in dairy prices is expected, forecast Glanbia, as the company posted a profit jump in its half year results.
Israel-based flavours, botanicals and speciality ingredients player Frutarom has reported lower profits in Q2, with raw material hikes cited as the principal cause.
Irish dairy and ingredients group Kerry has turned in a”solid” first half of 2011 that saw it increase volumes, weather raw material price hikes, and see success in a “go-to-market”...
UK analysts are forecasting 6-7% growth in sucralose for Tate & Lyle Splenda version of the sweetener which leads the segment globally.
Hans-Christian Ambjerg, president of DSM Food Specialties, goes head to head with FoodNavigator.com on commodity prices, emerging markets and acquisition strategy.
French botanicals supplier Naturex has seen its 2011 Q1 net profit double from €2.4m to €4.8m on revenues of €64m, as benefits of its 2009 expansion kick in.
DSM’s head of global marketing in human nutrition and health, Gareth Barker, explains why it has bought a carotenoid supplier (approval permitting), how the Martek acquisition is progressing, and why...
US chemical group DuPont has successfully completed its tender offer for Danisco, as 92.2 percent of outstanding shares in the Danish food ingredients firm were tendered by Friday’s deadline, DuPont...
The European Commission today approved DuPont’s €4.5bn offer for Danish probiotics, enzymes and ingredients giant Danisco but the deal remains in doubt as to date only 6% of Danisco shareholders...
Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of...